PFRree
Latest News
Contact us
Send a Release
Login
Create Free Account
Login
Create Free Account
Cmtausap
·
Newsroom
Charcot-Marie-Tooth Association Enters Collaboration with Affectis to Advance Therapies for CMT1A
The Charcot-Marie-Tooth Association (CMTA) announced today that it has entered into a collaboration with Affectis Pharmaceuticals AG to evaluate the efficacy of advanced Affectis compounds in neurological and behavioral models of CMT1A.
April 21, 2015
©2013-2022 pressnews.biz